Holen Sie sich die Stockscreener-App
0.00
100.00%
-0.2012
Handel nachbörslich:
.20
0.20
+
Schlusskurs vom Vortag:
$0.2012
Offen:
$0
24-Stunden-Volumen:
0
Relative Volume:
0.00
Marktkapitalisierung:
$9.52M
Einnahmen:
-
Nettoeinkommen (Verlust:
$-28.54M
KGV:
0.00
EPS:
-0.64
Netto-Cashflow:
$-22.72M
1W Leistung:
-100.00%
1M Leistung:
-100.00%
6M Leistung:
-100.00%
1J Leistung:
-100.00%
1-Tages-Spanne:
$0.00
$0.00
1-Wochen-Bereich:
$0.00
$0.00
52-Wochen-Spanne:
$0.00
$1.94
Essa Pharma Inc Stock (EPIX) Company Profile
Firmenname
Essa Pharma Inc
Sektor
Branche
Telefon
(778) 331-0962
Adresse
SUITE 720, VANCOUVER, BC
Compare EPIX vs VRTX, REGN, ARGX, ALNY, ONC
| Aktien | Preis | Marktkapitalisierung | Umsatz | Nettogewinn | Free Cashflow | ENV |
|---|---|---|---|---|---|---|
EPIX
Essa Pharma Inc
|
0.00 | 9.52M | 0 | -28.54M | -22.72M | -0.64 |
|
VRTX
Vertex Pharmaceuticals Inc
|
486.03 | 126.21B | 12.07B | 3.95B | 3.19B | 15.33 |
|
REGN
Regeneron Pharmaceuticals Inc
|
790.81 | 82.64B | 14.34B | 4.50B | 3.77B | 41.56 |
|
ARGX
Argen X Se Adr
|
756.76 | 47.46B | 3.06B | 1.28B | 447.35M | 19.67 |
|
ALNY
Alnylam Pharmaceuticals Inc
|
325.07 | 44.15B | 3.71B | 313.75M | 465.38M | 2.2571 |
|
ONC
Beone Medicines Ltd Adr
|
314.36 | 35.08B | 4.98B | 69.60M | 525.67M | 0.5198 |
Essa Pharma Inc Stock (EPIX) Upgrades & Downgrades
| Datum | Aktion | Analytiker | Ratingänderung |
|---|---|---|---|
| 2024-11-04 | Herabstufung | Jefferies | Buy → Hold |
| 2024-11-04 | Herabstufung | Oppenheimer | Outperform → Perform |
| 2024-11-04 | Herabstufung | Piper Sandler | Overweight → Neutral |
| 2023-06-26 | Fortgesetzt | Oppenheimer | Outperform |
| 2021-03-04 | Eingeleitet | Piper Sandler | Overweight |
| 2021-01-11 | Bestätigt | H.C. Wainwright | Buy |
| 2020-11-02 | Eingeleitet | Jefferies | Buy |
| 2019-10-25 | Eingeleitet | Oppenheimer | Outperform |
Alle ansehen
Essa Pharma Inc Aktie (EPIX) Neueste Nachrichten
Dip Buying: Is ESSA Pharma Inc a speculative investmentJuly 2025 News Drivers & Low Risk Entry Point Guides - baoquankhu1.vn
Is ESSA Pharma Inc. benefiting from innovation trendsFed Meeting & Safe Entry Trade Signal Reports - mfd.ru
What’s the beta of ESSA Pharma Inc. stockQuarterly Performance Summary & Free Expert Verified Stock Movement Alerts - mfd.ru
Big Money Moves: Can Johnson Controls International plc stock outperform in a bear marketJuly 2025 Trends & Community Trade Idea Sharing - baoquankhu1.vn
Targets Report: How sensitive is ESSA Pharma Inc to inflation2025 Market Trends & Verified Momentum Stock Alerts - baoquankhu1.vn
What is ESSA Pharma Inc. s 5 year growth outlookForecast Cut & Free Reliable Trade Execution Plans - mfd.ru
Aug Final Week: Is ESSA Pharma Inc undervalued by DCF analysis2025 Technical Overview & Consistent Profit Alerts - baoquankhu1.vn
Breakout Move: Why ESSA Pharma Inc stock is a must watch in 2025Earnings Beat & Accurate Entry/Exit Alerts - Bộ Nội Vụ
Breakout Watch: Is ESSA Pharma Inc a good stock for dollar cost averagingJuly 2025 Momentum & Weekly High Momentum Picks - baoquankhu1.vn
Aug Macro: How rising interest rates impact ESSA Pharma Inc stockOptions Play & Real-Time Sentiment Analysis - Bộ Nội Vụ
ESSA Pharma (EPIX) Stock Forecast & Price Prediction 2026–2030 - CoinCodex
Can ESSA Pharma Inc stock resist sector downturnsJuly 2025 Market Mood & Growth Focused Entry Reports - moha.gov.vn
Will ESSA Pharma Inc. stock pay special dividendsQuarterly Earnings Report & High Conviction Buy Zone Picks - DonanımHaber
Is ESSA Pharma Inc. stock resilient to inflationTrade Ideas & Expert Approved Momentum Ideas - Улправда
Is ESSA Pharma Inc. stock a top pick in earnings seasonMarket Performance Summary & Capital Efficient Trading Techniques - DonanımHaber
Is ESSA Pharma Inc. stock in correction or buying zonePortfolio Growth Summary & Free AI Powered Buy and Sell Recommendations - Улправда
Can ESSA Pharma Inc. stock resist sector downturns2025 Top Decliners & Low Risk High Win Rate Stock Picks - DonanımHaber
ESSA Pharma Amends Agreement with XenoTherapeutics, Adjusts Shareholder Terms - MSN
CanadaInvestors In Essa Pharma Inc. (NASDAQ: EPIX) Are Urged To Contact Siskinds LLP About Its Investigation Into A Potential Class Action - Mondaq
Support Test: Is ESSA Pharma Inc. stock in correction or buying zoneJuly 2025 Closing Moves & Weekly High Return Stock Opportunities - moha.gov.vn
Investors in Essa Pharma Inc. (NASDAQ: EPIX) are urged to contact Siskinds LLP about its investigation into a potential class action - The Globe and Mail
What analyst consensus says on ESSA Pharma Inc. stockWeekly Stock Summary & AI Powered Market Entry Ideas - Newser
Can ESSA Pharma Inc. stock deliver strong Q4 earningsTrade Volume Report & Real-Time Stock Price Movement Reports - newser.com
Is ESSA Pharma Inc. stock cheap compared to fundamentalsPortfolio Risk Report & Daily Chart Pattern Signal Reports - newser.com
Will ESSA Pharma Inc. stock split again soon2025 Macro Impact & Free Accurate Trade Setup Notifications - newser.com
Is ESSA Pharma Inc. stock a buy in volatile marketsInsider Buying & Weekly Market Pulse Alerts - newser.com
Is ESSA Pharma Inc. stock trading at a premium valuationJuly 2025 Trade Ideas & Safe Swing Trade Setup Alerts - newser.com
Using AI based signals to follow ESSA Pharma Inc.Gap Up & Free Fast Entry Momentum Trade Alerts - newser.com
Can ESSA Pharma Inc. stock resist market sell offs2025 Market Sentiment & Free High Accuracy Swing Entry Alerts - newser.com
What does recent volatility data suggest for ESSA Pharma Inc.Dip Buying & Low Drawdown Trading Techniques - newser.com
How moving averages guide ESSA Pharma Inc. tradingAnalyst Downgrade & Weekly High Momentum Picks - newser.com
How ESSA Pharma Inc. stock trades before earningsWatch List & Stepwise Trade Signal Guides - newser.com
Repare finds fix as biotech agrees to XenoTherapeutics buyout - Fierce Biotech
Will ESSA Pharma Inc. stock outperform value stocksMarket Activity Report & Free Technical Confirmation Trade Alerts - newser.com
What analysts say about ESSA Pharma Inc stockSector-Based Investing & What the Pros Are Saying About This Stock - earlytimes.in
Can ESSA Pharma Inc. stock attract ESG capital inflowsIPO Watch & AI Enhanced Market Trend Forecasts - Fundação Cultural do Pará
Finanzdaten der Essa Pharma Inc-Aktie (EPIX)
Umsatz
Nettogewinn
Free Cashflow
ENV
2.90%
2.73%
In Yahoo öffnen
|
In Google öffnen
|
In Finviz öffnen
|
In MarketWatch öffnen
|
Öffnen Sie in EDGAR
|
Offen in Reuters
Kapitalisierung:
|
Volumen (24h):